Eli Lilly (NYSE:LLY) recently announced several significant events, including promising trial results for baricitinib in ...
Tirzepatide and Semaglutide Improve Weight Loss, Cardiovascular Conditions, but Deemed Too Expensive
Weight loss drugs like tirzepatide and semaglutide are growing in popularity and offer significant health benefits, but they ...
"People come together, operators, with their supervisors at 6 a.m. every morning, and they talk about what issues they have and how they propose to solve it. Those get escalated through all levels of ...
Hims & Hers Health (NYSE:HIMS) shares were on a massive run, but that momentum hit a wall recently. Since its peak on ...
Altimmune said on Thursday that it plans to test its lead experimental obesity drug, pemvidutide, to potentially treat alcohol use disorder and alcohol-associated liver disease. WHY IT'S IMPORTANT ...
Eli Lilly has raised its revenue guidance for 2024 ... Tirzepatide-based medicines Mounjaro for diabetes and Zepbound for obesity have led the charge, contributing $3.1 billion and $1.2 billion ...
Investor's Business Daily on MSN9h
Stock Market Correction: Trump Tariffs Triggers Sell-Off Despite Tame Inflation: Weekly ReviewThe major indexes suffered another week of sharp losses as Trump tariffs ramped up, shrugging off tame inflation.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback